Chlamydia trachomatis Antibody Test
🦠 Chlamydia trachomatis IgG/IgM Antibody Test
A Complete Clinical Guide for Infertility, PID, and Chronic Genital Infection Evaluation
1. What is Chlamydia trachomatis?
Chlamydia trachomatis is one of the most common sexually transmitted pathogens worldwide, often presenting without symptoms, particularly in women. As an obligate intracellular gram-negative-like organism, it infects the urogenital tract and can lead to:
- Chronic cervicitis
- Pelvic inflammatory disease (PID)
- Tubal damage and infertility
- Ectopic pregnancy
- Neonatal conjunctivitis and pneumonia
While NAAT (PCR) is the gold standard for diagnosing active infection, serology (IgG, IgM) is used as a supplementary tool—primarily in infertility evaluations, chronic infection suspicion, or unclear past medical history.
2. Purpose of IgG/IgM Antibody Testing
🔍 IgM Antibody
- Indicates recent or acute infection
- Useful when symptoms are vague or PCR results are negative
- Helpful in suspected neonatal chlamydial pneumonia (IgM elevation supports diagnosis)
🔬 IgG Antibody
- Reflects past exposure
- Highly relevant in:
- Tubal factor infertility evaluation
- Chronic or ascending genital infection suspicion
- Women with repeated PID episodes
- Persistent IgG can remain for years regardless of treatment
3. Testing Method: ELISA (Enzyme-Linked Immunosorbent Assay)
Principle
- Antigen-coated wells bind patient IgG/IgM
- Enzyme-labeled anti-human antibody added
- Colorimetric reaction measured by absorbance
- Values compared with cut-off for positive/negative result
Strengths
- High-throughput processing
- Quantitative or qualitative results
- Relatively standardized across laboratories
Limitations
- Cross-reactivity with other Chlamydia species
- Lower sensitivity than PCR for acute infection
- IgM false positives (autoimmune disease, rheumatoid factor)
4. Reference Ranges (Example Only)
Each laboratory’s manufacturer cut-offs may vary.
| Antibody | Negative | Borderline | Positive |
|---|---|---|---|
| IgG | <0.90 | 0.90–1.10 | >1.10 |
| IgM | <0.90 | 0.90–1.10 | >1.10 |
5. Clinical Significance
✔ 1) IgM Positive
Indicates acute or recent infection
Women: cervicitis, urethritis, early PID
Men: urethritis, epididymitis
Neonates: IgM elevation supports congenital or perinatal infection
✔ 2) IgG Positive
Indicates past infection, but clinically important for fertility workup.
Associations:
- Tubal factor infertility
- Chronic pelvic inflammatory disease
- Silent upper genital tract infection
- Adhesions or hydrosalpinx risk
✔ 3) Both IgG(+), IgM(+)
Suggests persistent, chronic, or recently reactivated infection
Especially relevant when:
- PCR negative but symptoms persist
- Longstanding pelvic pain
- Recurrent PID episodes
✔ 4) Both Negative
- Does not exclude acute infection (early seroconversion window)
- If PCR negative → infection unlikely
- Re-test if symptoms strongly suggest infection
6. Associated Diseases
- Urethritis
- Cervicitis
- Pelvic inflammatory disease (PID)
- Tubal obstruction or hydrosalpinx
- Infertility (tubal factor)
- Ectopic pregnancy
- Neonatal conjunctivitis
- Neonatal chlamydial pneumonia
7. Important Considerations (Pitfalls & Cautions)
⚠ 1) Not a primary test for acute diagnosis
PCR/NAAT is the gold standard
⚠ 2) False-positive IgM
- Autoimmune disease (rheumatoid factor)
- Cross-reactivity with other Chlamydia species
⚠ 3) IgG ≠ current infection
IgG persistence is common
Interpret only with clinical context and fertility workup findings (HSG, ultrasound)
⚠ 4) Not diagnostic for infertility alone
IgG positivity should never be used as a single infertility diagnosis criterion
→ Combine with imaging, history, STI screening
8. Practical Interpretation Summary
| Result Pattern | Interpretation |
|---|---|
| IgM (+) | Acute or recent infection; neonatal infection possible |
| IgG (+) | Prior infection; useful in infertility evaluation |
| IgG (+) & IgM (+) | Possible chronic or persistent infection |
| IgG (–), IgM (–) | No evidence of past or present infection; early infection still possible |
9. References
- CDC. STI Treatment Guidelines, 2021
- WHO Factsheet: Chlamydia trachomatis
- Hoenderboom et al. Clin Microbiol Infect
- Schachter J. N Engl J Med. Chlamydial infections
- Peeling RW. Nat Rev Microbiol. Serological diagnosis of Chlamydia